by University of Basel High-throughput drug screen reveals estrogen receptor α (ERα) induction in triple-negative breast cancer (TNBC) upon polo-like kinase 1 (PLK1) inhibition. A Schematic of the high-throughput drug screen to identify inhibitors that induce ERα signaling in TNBC. Cells without active ERα signaling do not express GFP, whereas cells with active ERα signaling...
